GTLB vs LIF
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
GTLB exhibits severe fundamental weakness, highlighted by a Piotroski F-Score of 2/9, placing it in the 'Weak' health category. Despite strong gross margins of 87.38% and consistent revenue growth of 23.2%, the company is struggling with negative profitability and a catastrophic price collapse (-54.8% over the last year). Heavy insider selling totaling $59.19M and a technical trend score of 0/100 further reinforce a bearish outlook, suggesting that the current price decline may not yet have found a definitive floor despite analyst buy recommendations.
LIF presents a contradictory profile: strong growth and profitability metrics are offset by a weak Piotroski F-Score of 3/9, indicating deteriorating fundamental health. While the current price of $38.10 is well below the growth-based intrinsic value of $52.22, it trades at a significant premium to the Graham Number ($9.58). The stock is currently in a severe technical downtrend, losing over 63% of its value in the last six months, compounded by bearish insider selling. Despite these red flags, the low P/E relative to the tech sector and strong revenue growth maintain a neutral outlook rather than a fully bearish one.
Compare Another Pair
Related Comparisons
GTLB vs LIF: Head-to-Head Comparison
This page compares GitLab Inc. (GTLB) and Life360, Inc. (LIF) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.